保留幽门胃切除术治疗胃中段癌合并胃窦高危病变的安全性:与内镜黏膜下剥离术的比较
这项单中心回顾性研究纳入2013—2015年接受保留幽门胃切除术(PPG,3 cm胃窦袖套)的362例胃中段癌患者和接受内镜黏膜下剥离术(ESD)的139例患者,评估残胃异时性胃肿瘤(mGN)的安全性。ESD组mGN发生率为6.5%(9/139),其中2例位于3 cm胃窦袖套;PPG组mGN发生率为0.6%,均位于近端残胃。结论认为PPG在mGN发生方面是安全选择,但需对长胃窦袖套和长期随访进一步研究。
要点
- PPG术后mGN发生率低(0.6%),且均位于近端残胃。
- ESD组mGN发生率为6.5%,其中仅1.4%位于3 cm胃窦袖套。
- 同步肿瘤或中重度肠化生是ESD组mGN的危险因素。
核心结论
- 在本系列中,保留幽门胃切除术在异时性腺瘤或癌发生方面是安全的治疗选择。
- 尽管PPG后3 cm胃窦袖套内mGN发生率低,但同步肿瘤或中重度肠化生是ESD组mGN的危险因素,需进一步研究更长胃窦袖套和长期随访。
研究设计与样本
- 分析ESD组胃窦组织病理学特征以探究mGN危险因素,并比较PPG组胃窦mGN的估计与实际发生率。
主要发现
- ESD组mGN发生率为6.5%(9/139)。
- 同步腺瘤(OR 8.46;95%CI 1.55-46.34)、癌(OR 15.71;95%CI 2.67-92.56)和中重度肠化生(OR 9.77;95%CI 1.14-83.92)与总体mGN风险升高相关。
- 上述因素与局限于胃窦的mGN无显著关联。
- ESD组9例mGN中2例(1.4%)位于3 cm胃窦袖套。
- PPG组2例mGN(0.6%)均位于近端残胃。
临床怎么用
- PPG可作为胃中段cT1N0M0胃癌合并胃窦高危病变的安全手术选项。
- 对合并同步肿瘤或中重度肠化生的患者,术后应关注残胃mGN监测。
局限性
- 单中心回顾性研究设计。
- PPG组胃窦组织病理学特征无法确定。
- 需更长胃窦袖套和长期随访的进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Pylorus-preserving gastrectomy (PPG) is a surgical treatment option for cT1N0M0 gastric cancer located in the middle third of the stomach. However, data for the long-term post-PPG clinical outcomes related to metachronous gastric neoplasms (mGNs) in the residual stomach are currently lacking. Therefore, we aimed to evaluate the safety of PPG by focusing on mGNs. METHODS: In this single-center, retrospective study, we reviewed the data for 362 patients who underwent PPG with a 3-cm antral cuff and 139 who underwent endoscopic submucosal dissection (ESD) for middle-third gastric cancer between January 2013 and December 2015. The histopathologic features of the antrum in the ESD group, which could not be determined in the PPG group, were analyzed to investigate the risk factors for mGNs. The estimated and actual incidence of mGNs in the antrum were compared in the PPG group. RESULTS: The incidence of mGNs was 6.5% (9/139) in the ESD group. The presence of a synchronous adenoma (odds ratio [OR], 8.46; 95% confidence interval [CI], 1.55-46.34), carcinoma (OR, 15.71; 95% CI, 2.67-92.56) and moderate-to-severe intestinal metaplasia (OR, 9.77; 95% CI, 1.14-83.92) were associated with a higher risk of overall mGNs. However, when confined to the antrum, no significant association was observed between these factors and mGNs. In the ESD group, 2 of 9 mGNs (1.4%) were located at the 3-cm antral cuff. In the PPG group, both mGNs (0.6%) were located in the proximal remnant stomach. CONCLUSION: Pylorus-preserving gastrectomy was a safe therapeutic option with regard to the occurrence of metachronous adenomas or carcinomas in our series. Despite the low mGN incidence in the 3-cm antral cuff after PPG, the presence of synchronous neoplasms or moderate-to-severe intestinal metaplasia was a risk factor for mGNs in the ESD group; thus, further studies on longer antral cuffs with long-term follow-up are needed.
引用
- Choi J, Kim S, Chung H, et al. Safety of pylorus-preserving gastrectomy for gastric cancer combined with antral high-risk lesions: a comparison with endoscopic submucosal dissection. Surg Endosc. 2022. PMID: 36517703. doi:10.1007/s00464-022-09791-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。